People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback